Table 3 Changes in frequency and % in outcomes 3 and 12 months post-treatment
From: Opiate agonist treatment to improve health of individuals with opioid use disorder in Lebanon
n (%) | p value | |
|---|---|---|
Arrested last 3 months—3-month assessment (n = 86) | ||
Baseline | 62 (72.1%) | |
3 months | 7 (8.1%) | 0.001 |
Arrested last 3 months—12-month assessment (n = 38) | ||
Baseline | 24 (70.6%) | |
12 months | 1 (2.6%) | 0.001 |
Working—3-month assessment (n = 86) | ||
Baseline | 24 (27.9%) | |
3 months | 52 (60.5%) | 0.02 |
Working—12-month assessment (n = 38) | ||
Baseline | 12 (31.6%) | 0.07 |
12 months | 30 (78.9%) | |
N times overdose—3-month assessment (n = 86) | ||
Baseline | 12 (14.0%) | |
3 months | 3 (3.5%)* | 0.02 |
N times overdose—12-month assessment (n = 38) | ||
Baseline | 8 (21.1%) | |
12 months | 1 (2.6%) | 0.03 |
Heroin use disorder—3-month assessment (n = 86) | ||
Baseline | 72 (100%) | |
3 months | 5 (6.9%) | ≤ 0.001 |
Heroin use disorder—12-month assessment (n = 38) | ||
Baseline | 38 (100%) | |
12 months | 1 (2.6%) | ≤ 0.001 |
Cocaine use disorder—3-month assessment (n = 86) | ||
Baseline | 13 (18%) | |
3 months | 1 (1.3%) | p = 0.04 |
Cocaine use disorder—12-month assessment (n = 38) | ||
Baseline | 6 (15.8%) | |
12 months | 1 (2.6%) | p = 0.01 |
Marijuana use disorder—3-month assessment (n = 86) | ||
Baseline | 18 (25%) | |
3 months | 6 (9.7%) | p = 0.01 |
Marijuana use disorder—12-month assessment (n = 38) | ||
Baseline | 8 (21%) | |
12 months | 3 (7.8%) | 0.04 |